BAIONI CHIARA

(2025). Development of a CAF model to investigate the potential of a TME-targeted TRAIL gene therapy approach for cancer eradication. (Tesi di dottorato, , 2025). Detail

Barbieri, L., Salvioni, L., Banfi, A., Garbujo, S., Fiandra, L., Baioni, C., et al. (2025). Dual-Targeting Strategy to Repurpose Cetuximab with HFn Nanoconjugates for Immunotherapy of Triple-Negative Breast Cancer. ACS APPLIED MATERIALS & INTERFACES [10.1021/acsami.5c06626]. Detail

Baioni, C., Innocenti, M., Colombo, M., Prosperi, D. (2024). Killing cancer cells by targeting the tumor microenvironment: study of TRAIL journey in a CAFs model. Intervento presentato a: BtBsDay 2024, Milano, Italia. Detail

di Miceli, N., Baioni, C., Barbieri, L., Danielli, D., Sala, E., Salvioni, L., et al. (2024). TGF-β Signaling Loop in Pancreatic Ductal Adenocarcinoma Activates Fibroblasts and Increases Tumor Cell Aggressiveness. CANCERS, 16(21) [10.3390/cancers16213705]. Detail

Del Nero, M., Colombo, A., Garbujo, S., Baioni, C., Barbieri, L., Innocenti, M., et al. (2023). Advanced Cell Culture Models Illuminate the Interplay between Mammary Tumor Cells and Activated Fibroblasts. CANCERS, 15(9) [10.3390/cancers15092498]. Detail